Published in Int J Radiat Biol on April 01, 2000
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest (2002) 1.29
Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets (2013) 1.27
Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist (2010) 1.23
[Frequency of terminally differentiated fibroblasts in the synovial membrane of rheumatoid arthritis patients]. Z Rheumatol (2004) 0.82
Molecular responses of radiation-induced liver damage in rats. Mol Med Rep (2014) 0.79
The association between TGF-β1 polymorphisms and radiation pneumonia in lung cancer patients treated with definitive radiotherapy: a meta-analysis. PLoS One (2014) 0.79
Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats. J Radiat Res (2014) 0.77
Simvastatin attenuates radiation-induced salivary gland dysfunction in mice. Drug Des Devel Ther (2016) 0.75
Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects. Front Immunol (2017) 0.75
Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med (1983) 3.49
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem (1982) 2.59
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33
Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A (1988) 2.00
The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease. J Biol Chem (1982) 1.70
Cellular basis of radiation-induced fibrosis. Radiother Oncol (1995) 1.52
Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol (2002) 1.46
Radiation induced CNS toxicity--molecular and cellular mechanisms. Br J Cancer (2001) 1.44
[Gamma knife versus stereotactic linear accelerator. Utilization, clinical results and cost-benefit relations]. Radiologe (1996) 1.40
[Emergency rescue in accidents with HDR afterloading units]. Strahlenther Onkol (1999) 1.39
[Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment?]. Strahlenther Onkol (1996) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000]. Pneumologie (2001) 1.28
Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol (2002) 1.28
Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem Photobiol (1998) 1.21
Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol (1994) 1.18
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci U S A (1999) 1.15
Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am J Kidney Dis (1991) 1.15
Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics (1994) 1.14
Cerebral metastases in extrapulmonary cell carcinoma. Implications for the use of prophylactic cranial irradiation. Strahlenther Onkol (2012) 1.12
Limited disease of extra-pulmonary small cell carcinoma. Impact of local treatment and nodal status, role of cranial irradiation. Strahlenther Onkol (2012) 1.12
Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res (1991) 1.12
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol (2005) 1.11
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06
Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys (2000) 1.06
Methods for analysis of censored tumor growth delay data. Radiat Res (1990) 1.05
Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer (2004) 1.04
Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys (2001) 1.04
AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics (2005) 1.03
Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol (1998) 1.01
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer (1994) 1.00
Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96. J Clin Oncol (2001) 0.99
Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis. Oncogene (2000) 0.99
Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer (2000) 0.99
In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res (1999) 0.97
Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene (2001) 0.97
The suppression of heterotopic ossifications: radiation versus NSAID therapy--a prospective study. J Arthroplasty (1998) 0.96
Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology (2006) 0.96
Treatment of early stage testicular seminoma. J Cancer Res Clin Oncol (2001) 0.95
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells in vitro. Int J Radiat Biol (2003) 0.95
Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr (1998) 0.93
Thermoradiotherapy for locally recurrent breast cancer with skin involvement. Int J Hyperthermia (2001) 0.93
Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol (1998) 0.92
PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology (2000) 0.91
Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. J Neurooncol (2000) 0.91
The role of interstitial cells in the progression of renal diseases. J Am Soc Nephrol (1992) 0.90
The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol (1998) 0.90
[A new working shift model for anesthesiologists: an analysis 3 years after implementation]. Anaesthesist (2012) 0.89
Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiother Oncol (1999) 0.88
Abnormal collagen metabolism in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (1984) 0.88
The role of radiotherapy in the treatment of craniopharyngioma--indications, results, side effects. Front Radiat Ther Oncol (1999) 0.87
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine. Ann Oncol (2007) 0.87
Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol (2001) 0.87
Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr (2004) 0.87
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant (2003) 0.87
Differential degradation of [35S]methionine polypeptides in Duchenne muscular dystrophy skin fibroblasts in vitro. Proc Natl Acad Sci U S A (1986) 0.87
Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer. Strahlenther Onkol (2012) 0.87
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol (2000) 0.86
Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys (1997) 0.86
Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis. Exp Nephrol (1995) 0.86
Radiotherapy of soft tissue sarcomas with neutrons or a neutron boost. Br J Radiol (1984) 0.86
70 Gy or more: which dose for which prostate cancer? J Cancer Res Clin Oncol (2005) 0.86
The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene (1999) 0.86
Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol (1991) 0.86
Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol (1994) 0.86
Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells. Kidney Int (1992) 0.86
Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. Strahlenther Onkol (2012) 0.85
Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand. Radiat Res (1998) 0.85
The underlying cellular mechanism of fibrosis. Kidney Int Suppl (1996) 0.85
Thermoradiotherapy of the chest wall in locally advanced or recurrent breast cancer with marginal resection. Int J Hyperthermia (2005) 0.85
Alterations of protein degradation and 2-D protein pattern in muscle cells of MDX and DMD origin. Biochem Biophys Res Commun (1992) 0.85
Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol (2000) 0.85
Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol (1998) 0.85
Transcriptional downregulation of ATM by EGF is defective in ataxia-telangiectasia cells expressing mutant protein. Oncogene (2001) 0.84
Paclitaxel-induced radiation recall dermatitis. Ann Oncol (1996) 0.84
Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study. Radiat Oncol (2006) 0.84
Current and potential role of thermoradiotherapy for solid tumours. Onkologie (2003) 0.84
Ionizing radiation and the activation of caspase-8 in highly apoptosis-sensitive lymphoma cells. Int J Radiat Biol (1999) 0.84
Clinical indications and biological mechanisms of splenic irradiation in autoimmune diseases. Strahlenther Onkol (2001) 0.84
Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation. Nuklearmedizin (2010) 0.83
Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study. Cancer (2001) 0.83
Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas. J Cancer Res Clin Oncol (2001) 0.83
Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol (1998) 0.83
Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitro. Exp Cell Res (1990) 0.83
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases. Anticancer Drugs (2000) 0.83
Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer (2003) 0.82
Spontaneous and radiation-induced differentiationof fibroblasts. Exp Gerontol (2000) 0.82
Changes of fibrosis-related parameters after high- and low-LET irradiation of fibroblasts. Int J Radiat Biol (2001) 0.82
Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol (2000) 0.82
How relevant is secondary leukaemia for initial treatment selection in Hodgkin's disease? Eur J Cancer (1994) 0.82